American multinational pharmaceutical company Pfizer requested on Tuesday the emergency-use authorization from the Food and Drug Administration (FDA) for their Covid-19 antiviral pill.
The alternative treatment for the coronavirus is the second pill to be considered by the FDA since Merck’s announcement that they were going to seek approval for their own variation of the antiviral pill.
Pfizer requests authorization for antiviral pill
The treatment, named Paxlovid, is a regimen of antiviral pills taken orally that aims to treat mild to moderate cases of the coronavirus in people who are at a higher risk of hospitalization or even death.
Pfizer’s request comes in the wake of the company announcing that their Covid-19 antiviral pill had reduced the risk of hospitalization and death by about 89% in people who are categorized under “high risk”, according to their interim data.
The trial was stopped prematurely because of the “overwhelming efficacy’ that was seen in the results.
The trials included infected adult patients who were at high risk of contracting severe illness and after a month of trials, no deaths were reported in the trialists who were administered the pill within 3 days of their onset of symptoms.
However, seven deaths were reported in the placebo group.
Pfizer CEO: “Moving as quickly as possible”
Albert Bourla, the Chief Executive Officer and Chairman of Pfizer, said in a statement that they are removing as quickly as possible in their efforts to get the treatment into the hands of patients.
Bourla highlighted that they are looking forward to working with the FDA on the review of their application,.
Britain first country to approve antiviral pill
Britain became the first country to approve antiviral pills under certain conditions, to Merck’s application and the company said that their pill can reduce hospitalization and deaths arising from Covid-19 by about 50%.
They had applied for the emergency use authorization in October.
Covid-19 in the US
The Covid-19 situation in the US had subsided over the last year, although it could’ve been handled better if it wasn’t for the downplaying of the coronavirus during the early onset of the pandemic by former president Donald Trump.